COVID-19. A major risk to health, economies & markets. Australian perspective

This page seeks to summarise some of the issues as I see them. Anne de Gheest's clinical updates (see below), which discuss the very latest COVID research, have been extremely valuable in helping me to understand how dangerous COVID variants are and the massive implications of Long-COVID. COVID now seems likely to be with us for many years to come - and current research 20/Apr/21 indicates that it could become far more dangerous over the next year or two.

27/Apr/21 The massive explosion of COVID in India shows what can happen when you become too arrogant and complacent with COVID, like Australia has now become.  Given these new dangerous COVID variants are now flying into Australia every day on planes, it is an now unacceptably high risk to continue to quarantine arrivals in hotels in the centre of our big cities - a disaster waiting to happen. The cost to Australia, if this current system fails would be huge. Australia urgently needs to create a national quarantine station in a far safer area.


Related pages are here:-

Anne de Gheest updates: 

Other important references:

Royal Australian College of General Practitioners

  • "Current COVID vaccines could be ineffective by next year: epidemiologists"

    •  31March2021

      • "Two-thirds of epidemiologists who took part in a recent global survey have predicted it will be less than a year before SARS-CoV-2 mutates to such an extent that the majority of first generation COVID vaccines are rendered ineffective and new or modified candidates are required."

      • "Variants of concern have already emerged in South Africa, the US, India and Brazil, and Yale University’s Associate Professor Gregg Gonsalves said the fact that millions of people around the world are still contracting the disease means new mutations will arise every day."

      • There is some concern that the AstraZeneca vaccine shows much less protection against the South African strain [B.1.351], but it was quite a small study that did not examine whether there was still protection against severe disease.'

Establishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing


    • "WHO and its partners are seeking to expand the capacity of low- and middle-income countries (LMICs) to produce COVID-19 vaccines and scale up manufacturing to increase global access to these critical tools to bring the pandemic under control.   WHO will facilitate the establishment of one (or more, as appropriate) technology transfer1 hub(s) that will  use a hub and spoke model (REF) to transfer a comprehensive technology package and provide appropriate training to interested manufacturers in LMICs. This initiative will initially prioritize the mRNA-vaccine technology but could expand to other technologies in the future."

    • The reasons why WHO decided to advance immediately on mRNA vaccines are as follows:

      • They have proven extremely efficacious in protecting against COVID-19, and protection is maintained to a large degree against variants;

      • This technology is very flexible and allows relatively rapid adaptation of the vaccine to variants, if needed;

      • They can be produced by manufacturers of medicines and medical active substances in addition to vaccines;

      • Many technical features are free of Intellectual Property Rights in many countries of the world.


    • "We could have started something like this here last year. Too rigid in our thinking. Establishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing"

New COVID variants can quickly overwhelm a country.

Postal Address

PO Box 739

Kenmore, Queensland



T: 07 3202 6044

M: 0434 905 885

(use the mobile number)